
Medical Oncologist @A.C.Camargo Cancer Center #oncogenetics #GUoncology #sarcoma
São Paulo, Brasil
Joined February 2018
- Tweets225
- Following235
- Followers536
- Likes752
Maria Nirvana Formiga, MD, PhD retweeted
🤓Ok, I think you will find this interesting:
How drugs should be named under the 'new' nomenclature:
- Trastuzumab (Herceptin) -> Trastatug
- Pembrolizumab (Keytruda) -> Pembrostotug
- Atezolizumab (Tecentriq) -> Atezostobart
- Blinatumomab (Blincyto) -> Blinatamig
Will this happen?
Well, not with older drugs, but certainly with new ones.
If you want to learn more about this naming system, check out this thread!
Maria Nirvana Formiga, MD, PhD retweeted
In >230,000 individuals from the Helix Research Network, Lynch syndrome cancer risk varied substantially by gene @JCOOA_ASCO @kellyschiabor
MLH1/MSH2 showed the highest colorectal cancer risk, while PMS2 demonstrated markedly lower penetrance & later onset
ascopubs.org/doi/pdf/10.1200…
Maria Nirvana Formiga, MD, PhD retweeted
Todo lo que sabemos hoy sobre el cáncer de mama: diagnóstico, tratamientos y factores de riesgo lasedadesdetusalud.telva.com… via @uestudio_es @quironsalud @telva @elmundoes
Maria Nirvana Formiga, MD, PhD retweeted
Just started👉2025 United States #ProstateCancer Consensus Conference (USPCCC) 👉with @AlanBryce9 ‘s introductory remarks. @philkuo @cityofhope debating for PSMA PET for treatment selection. Caveat👉 Medical conditions with false positive PSMA PET lesions 👇@urotoday @PCFnews
Maria Nirvana Formiga, MD, PhD retweeted
Wonderful time with colleges from México and Brazil diving in thee prostate cancer Journey
@acccancercenter @StenioZequi José Augusto Rinck @thiagocmourao Daniel Garcia @nirvanaformiga @AldoLADETTINO @luciana45069110 @ederbrazaojr Rafael Zanotti – at Sao Paulo, Brazil
Maria Nirvana Formiga, MD, PhD retweeted
Huge congrats to #NizarTannirMD @MDAndersonNews who drove forward this impt trial (#PIVOT09) comparing pegylated #IL2/#nivolumab to #TKI; was a privelege to work w him & others (@nirvanaformiga @neerajaiims @Daniel_J_George) on this trial now in @JCO_ASCO. PFS & OS no different; RR a bit lower in experimental arm. We saw @brian_rini & @DrChoueiri present genomic data from #KN426 & #CLEAR at #ASCO24 & prev saw genomic data from #CM214 presented by @motzermd. Wish we had the opportunity to look at that here - given modest activity w #bempeg, could offer insights on which pts could get IO monotx - something we discuss often after #KN427 but do infrequently in practice.
Maria Nirvana Formiga, MD, PhD retweeted
A historic day for #kidneycancer & the field of #oncology as a whole at @ASCO #GU24. @DrChoueiri @DanaFarber & colleagues present the 1st randomized phase 3 study to show a survival advantage w adjuvant PD1 inhibition, reinforcing this approach as SOC. Proud of his tireless efforts on behalf of all of our patients.
Maria Nirvana Formiga, MD, PhD retweeted
Important data showing for the first time the benefit of ICI-TKI combo in the mCRPC patients. Greater benefit in a bad prognosis population @neerajaiims #GU24
Beautiful presentation by @neerajaiims @huntsmancancer of data from #CONTACT02, a P3 trial evaluating #cabozantinib & #atezolizumab in #prostatecancer. POSITIVE for 1 EP of PFS (HR 0.65) w a trend towards OS benefit at the time of interim analysis. Hoping this will be an option made available to our patients very soon. The 1st of many groundbreaking datasets to be presented at @ASCO #GU24!
Maria Nirvana Formiga, MD, PhD retweeted
FDA approves nirogacestat for desmoid tumors | FDA. #tumordesmoide @nirvanaformiga @acccancercenter fda.gov/drugs/resources-info… – at Sao Paulo, Brazil
Maria Nirvana Formiga, MD, PhD retweeted
Neste Novembro Azul, quando o mundo aponta para a conscientização sobre o cuidado com os tumores masculinos, o Congresso SBOC 23, traz sessões que exploram os avanços no tratamento destes tumores. Acesse congressosboc.com.br/program… e confira todas as sessões sobre câncer de próstata.
Maria Nirvana Formiga, MD, PhD retweeted
Replying to @myESMO
ESMO calls upon UN member states to ensure Universal Health Coverage benefit packages that encompass comprehensive cancer services for their entire population, considering that 1 in 5 individuals is anticipated to experience cancer in their lifetime.
@myESMO #ESMO23 @AndresC27622123 @Silke_Gillessen @OncoAlert @UN
Maria Nirvana Formiga, MD, PhD retweeted
Replying to @oncodaily @jrgralow @dinamired @lillian_siu @nr_pedhemonc @BourlonMaite @ProfGLongMIA @MyriamChalabi
Thank you for the recognition. Very honored to be among such brilliant women! @acccancercenter
Maria Nirvana Formiga, MD, PhD retweeted
dailynews.ascopubs.org/do/pa… find the link here!!
Maria Nirvana Formiga, MD, PhD retweeted
What a thoughtful distillation of tx approaches in the 2nd line & beyond from @TiansterZhang @utswcancer. Really enjoyed her thorough overview of exploratory approaches ranging from salvage IO to CAR-T! Lots of new modalities under investigation - the future is bright!
Maria Nirvana Formiga, MD, PhD retweeted
Maria Nirvana Formiga, MD, PhD retweeted
🙌Delighted to announce that the 2022 #CGAIGC Award for 2022 has been granted to 🥇@gitorrezan🥇
tinyurl.com/yux7crwk
Although @gitorrezan will not be at #CGAIGC22 she'll be recognized during our Award Ceremony in Nashville on Nov 10th from 4:30-6:00pm by Dr Elena Stoffel.
Maria Nirvana Formiga, MD, PhD retweeted
See great new work from @HHampel1 and team- Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study ascopubs.org/doi/full/10.120…












































